Harvard Systems Biologist Leading Innovation in Cellular Research and COVID-19 Response
Associated with :
Harvard UniversityMichael Springer, a Professor of Systems Biology at Harvard Medical School and co-director of HIVE, has established himself as a pioneering researcher and educator in cellular biology and systems analysis. After earning BS degrees in Chemistry and Biology from Stanford in 1996 and a PhD in Cell Biology from UC San Francisco in 2003, he has built an impressive career studying how evolution shapes cellular responses to environmental changes. His research encompasses yeast species analysis using advanced techniques like in vivo fluorescence and genetic approaches. Dr. Springer's contributions extend beyond traditional research, as he co-developed a computational skills course that has reached over 1,000 in-person students and 30,000 online learners. His work has earned support from prestigious organizations including NIH, NSF, DARPA, and IARPA. During the COVID-19 pandemic, he made remarkable contributions by developing novel sample collection technology, establishing Harvard's first CLIA certified lab, and overseeing more than 2.2 million COVID-19 tests in its first year. His current research focuses on developing new diagnostics and advancing microbial engineering for sustainable production, including innovative approaches to bioweathering for carbon dioxide removal and local food production.